AHSG and metabolic dysfunction-associated steatotic liver disease: Additionally, it has been shown that Fetuin-A plays a critical role in the pathophysiology of a number of diseases, including metabolic disorders, nonalcoholic fatty liver disease (NAFLD), insulin resistance (IR), type 2 diabetic mellitus (T2DM), cancers, and brain problems [8].